A Network Pharmacology-Based Analysis of Multi-Target, Multi-Pathway, Multi-Compound Treatment for Ovarian Serous Cystadenocarcinoma.
第一作者:
Dan-Dan,Xiong
第一单位:
Department of Pathology, First Affiliated Hospital of Guangxi Medical University, No. 6. Shuangyong Rd, Nanning, 530021, Guangxi, China.
作者:
主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);队列研究(Cohort Studies);囊腺癌, 浆液(Cystadenocarcinoma, Serous);药物释放系统(Drug Delivery Systems);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);基因调控网络(Gene Regulatory Networks);人类(Humans);信号传导(Signal Transduction);治疗结果(Treatment Outcome)
DOI
10.1007/s40261-018-0683-8
PMID
30097905
发布时间
2021-03-23
- 浏览6

Clinical drug investigation
909-925页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文